June 16, 2021
Recent Advance Articles
The FDA has approved the use of Cosentyx in patients 6 years old and older who are candidates for systemic therapy or phototherapy.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.